Faculty profile

Livia Garzia

ResearcherUniversity of Toronto

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Toronto directory, so their courses and email address may be missing. Find their university profile.

Livia Garzia

Researcher

Health Sciences

University of Toronto

Toronto, Ontario, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
2 publications in the last five years, latest in 2025.
Principal investigator on 1 research grant (1 CIHR), most recently in 2025.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

3,037

Citations

h-index

Collaborators

Grants

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Antisense Oligonucleotides Ependymoma Fusions Medulloblastoma Pediatric Cancer

Latest papers

A forward genetic screen identifies potassium channel essentiality in SHH medulloblastoma maintenance.
Developmental cell · 2025
Leptomeningeal metastases from solid tumors: A Society for Neuro-Oncology and American Society of Clinical Oncology consensus review on clinical management and future directions.
Neuro-oncology · 2024
Single allele loss-of-function mutations select and sculpt conditional cooperative networks in breast cancer.
Nature communications · 2021

All 25 publications

Latest funding

Targeting Gene Fusions in Pediatric Brain Tumors: A Personalized Medicine Approach
CIHR · 2025 · Principal investigator
$1,491,750
Defining the transcriptional dynamics and vulnerabilities of Ewing sarcoma along the disease trajectory, from initiation to metastasis
CIHR · 2024 · Co-investigator
$1,097,776
Defining the transcriptional dynamics and vulnerabilities of fusion-driven sarcomas along the disease trajectory, from initiation to metastasis
CIHR · 2023 · Co-investigator
$100,000

All 3 grants and awards

25 publications.

A forward genetic screen identifies potassium channel essentiality in SHH medulloblastoma maintenance.

Fan JJ, Erickson AW, Carrillo-Garcia J, Wang X, Skowron P, Wang X, Chen X, Shan G, Dou W, Bahrampour S, Xiong Y, Dong W, Abeysundara N, Francisco MA, Pusong RJ, Wang W, Li M, Ying E, Suárez RA, Farooq H, Holgado BL, Wu X, Daniels C, Dupuy AJ, Cadiñanos J, Bradley A, Bagchi A, Moriarity BS, Largaespada DA, Morrissy AS, Ramaswamy V, Mack SC, Garzia L, Dirks PB, Li X, Wanggou S, Egan S, Sun Y, Taylor MD, Huang X

Developmental cell2025

DOI: 10.1016/j.devcel.2025.01.001 PMID: 39862856

Leptomeningeal metastases from solid tumors: A Society for Neuro-Oncology and American Society of Clinical Oncology consensus review on clinical management and future directions.

Wilcox JA, Chukwueke UN, Ahn MJ, Aizer AA, Bale TA, Brandsma D, Brastianos PK, Chang S, Daras M, Forsyth P, Garzia L, Glantz M, Oliva ICG, Kumthekar P, Le Rhun E, Nagpal S, O'Brien B, Pentsova E, Lee EQ, Remsik J, Rudà R, Smalley I, Taylor MD, Weller M, Wefel J, Yang JT, Young RJ, Wen PY, Boire AA

Neuro-oncology2024

DOI: 10.1093/neuonc/noae103 PMID: 38902944

Single allele loss-of-function mutations select and sculpt conditional cooperative networks in breast cancer.

Schachter NF, Adams JR, Skowron P, Kozma KJ, Lee CA, Raghuram N, Yang J, Loch AJ, Wang W, Kucharczuk A, Wright KL, Quintana RM, An Y, Dotzko D, Gorman JL, Wojtal D, Shah JS, Leon-Gomez P, Pellecchia G, Dupuy AJ, Perou CM, Ben-Porath I, Karni R, Zacksenhaus E, Woodgett JR, Done SJ, Garzia L, Sorana Morrissy A, Reimand J, Taylor MD, Egan SE

Nature communications2021

DOI: 10.1038/s41467-021-25467-w PMID: 34475389

Modeling germline mutations in pineoblastoma uncovers lysosome disruption-based therapy.

Chung PED, Gendoo DMA, Ghanbari-Azarnier R, Liu JC, Jiang Z, Tsui J, Wang DY, Xiao X, Li B, Dubuc A, Shih D, Remke M, Ho B, Garzia L, Ben-David Y, Kang SG, Croul S, Haibe-Kains B, Huang A, Taylor MD, Zacksenhaus E

Nature communications2020

DOI: 10.1038/s41467-020-15585-2 PMID: 32286280

A Hematogenous Route for Medulloblastoma Leptomeningeal Metastases.

Garzia L, Kijima N, Morrissy AS, De Antonellis P, Guerreiro-Stucklin A, Holgado BL, Wu X, Wang X, Parsons M, Zayne K, Manno A, Kuzan-Fischer C, Nor C, Donovan LK, Liu J, Qin L, Garancher A, Liu KW, Mansouri S, Luu B, Thompson YY, Ramaswamy V, Peacock J, Farooq H, Skowron P, Shih DJH, Li A, Ensan S, Robbins CS, Cybulsky M, Mitra S, Ma Y, Moore R, Mungall A, Cho YJ, Weiss WA, Chan JA, Hawkins CE, Massimino M, Jabado N, Zapotocky M, Sumerauer D, Bouffet E, Dirks P, Tabori U, Sorensen PHB, Brastianos PK, Aldape K, Jones SJM, Marra MA, Woodgett JR, Wechsler-Reya RJ, Fults DW, Taylor MD

Cell2018First author

DOI: 10.1016/j.cell.2018.01.038 PMID: 29474906

A functional genomics approach to identify pathways of drug resistance in medulloblastoma.

Bertrand KC, Faria CC, Skowron P, Luck A, Garzia L, Wu X, Agnihotri S, Smith CA, Taylor MD, Mack SC, Rutka JT

Acta neuropathologica communications2018

DOI: 10.1186/s40478-018-0652-8 PMID: 30591080

Metastatic group 3 medulloblastoma is driven by PRUNE1 targeting NME1-TGF-β-OTX2-SNAIL via PTEN inhibition.

Ferrucci V, de Antonellis P, Pennino FP, Asadzadeh F, Virgilio A, Montanaro D, Galeone A, Boffa I, Pisano I, Scognamiglio I, Navas L, Diana D, Pedone E, Gargiulo S, Gramanzini M, Brunetti A, Danielson L, Carotenuto M, Liguori L, Verrico A, Quaglietta L, Errico ME, Del Monaco V, D'Argenio V, Tirone F, Mastronuzzi A, Donofrio V, Giangaspero F, Picard D, Remke M, Garzia L, Daniels C, Delattre O, Swartling FJ, Weiss WA, Salvatore F, Fattorusso R, Chesler L, Taylor MD, Cinalli G, Zollo M

Brain : a journal of neurology2018

DOI: 10.1093/brain/awy039 PMID: 29490009

miR miR on the wall, who's the most malignant medulloblastoma miR of them all?

Wang X, Holgado BL, Ramaswamy V, Mack S, Zayne K, Remke M, Wu X, Garzia L, Daniels C, Kenney AM, Taylor MD

Neuro-oncology2018

DOI: 10.1093/neuonc/nox106 PMID: 28575493

Therapeutic targeting of ependymoma as informed by oncogenic enhancer profiling

Mack SC, Pajtler KW, Chavez L, Okonechnikov K, Bertrand KC, Wang X, Erkek S, Federation A, Song A, Lee C

Nature2018216 citations

DOI: 10.1038/nature25169

Tailoring Medulloblastoma Treatment Through Genomics: Making a Change, One Subgroup at a Time.

Holgado BL, Guerreiro Stucklin A, Garzia L, Daniels C, Taylor MD

Annual review of genomics and human genetics2017

DOI: 10.1146/annurev-genom-091416-035434 PMID: 28475368

Something wrong or missing on this profile? Suggest a correction

Livia Garzia

Research

Latest papers

Latest funding

A forward genetic screen identifies potassium channel essentiality in SHH medulloblastoma maintenance.

Leptomeningeal metastases from solid tumors: A Society for Neuro-Oncology and American Society of Clinical Oncology consensus review on clinical management and future directions.

Single allele loss-of-function mutations select and sculpt conditional cooperative networks in breast cancer.

Modeling germline mutations in pineoblastoma uncovers lysosome disruption-based therapy.

A Hematogenous Route for Medulloblastoma Leptomeningeal Metastases.

A functional genomics approach to identify pathways of drug resistance in medulloblastoma.

Metastatic group 3 medulloblastoma is driven by PRUNE1 targeting NME1-TGF-&#x3b2;-OTX2-SNAIL via PTEN inhibition.

miR miR on the wall, who's the most malignant medulloblastoma miR of them all?

Therapeutic targeting of ependymoma as informed by oncogenic enhancer profiling

Tailoring Medulloblastoma Treatment Through Genomics: Making a Change, One Subgroup at a Time.

Targeting Gene Fusions in Pediatric Brain Tumors: A Personalized Medicine Approach

Defining the transcriptional dynamics and vulnerabilities of Ewing sarcoma along the disease trajectory, from initiation to metastasis

Defining the transcriptional dynamics and vulnerabilities of fusion-driven sarcomas along the disease trajectory, from initiation to metastasis

Frequent collaborators

Vijay Ramaswamy

Eric Bouffet

Uri Tabori

Nada Jabado

David Malkin

Annie Huang

Livia Garzia

Nada Jabado

Boleslaw Lach

Ute Bartels

Mathieu Lupien

Wei Wang

Jacek Majewski

Xi Huang

Cynthia Hawkins

Benjamin Haibe-Kains

Eldad Zacksenhaus

Jean Michaud

Abhaya Kulkarni

Robert Hammond

Sebastien Perreault

Jüri Reimand

Dalia Barsyte-Lovejoy

Metastatic group 3 medulloblastoma is driven by PRUNE1 targeting NME1-TGF-β-OTX2-SNAIL via PTEN inhibition.